Pharmaceutical giant Novartis will publish research on developing drugs to treat some of the deadliest antimicrobial-resistant pathogens as part of an initiative aimed at promoting further scientific efforts within the field.
Novartis donates data in effort to jump-start antibiotic development
Wes Kim, senior officer for Pew's Antibiotic Resistance Project, hopes sharing data in this format will encourage increased development of new antibiotics that will be effective against drug-resistant pathogens since the number of available treatment options has diminished.
Send us a letter
Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.